BACKGROUND: During 2004-2009, >12,000 children (<15 years old) initiated antiretroviral therapy (ART) in Mozambique. Nationally representative outcomes and temporal trends in outcomes were investigated. METHODS: Rates of death, loss to follow-up (LTFU) and attrition (death or LTFU) were evaluated in a nationally representative sample of 1054 children, who initiated ART during 2004-2009 at 25 facilities randomly selected using probability-proportional-to-size sampling. RESULTS: At ART initiation during 2004-2009, 50% were male; median age was 3.3 years; median CD4% was 13%; median CD4 count was 375 cells/μL; median weight-for-age Z score was -2.1. During 2004-2009, median time from HIV diagnosis to care initiation declined from 33 to 0 days (P = 0.001); median time from care to ART declined from 93 to 62 days (P = 0.004); the percentage aged <2 at ART initiation increased from 16% to 48% (P = 0.021); the percentage of patients with prior tuberculosis declined from 50% to 10% (P = 0.009); and the percentage with prior lymphocytic interstitial pneumonia declined from 16% to 1% (P < 0.001). Over 2652 person-years of ART, 183 children became LTFU and 26 died. Twelve-month attrition was 11% overall but increased from 3% to 22% during 2004-2009, mainly because of increases in 12-month LTFU (from 3% to 18%). CONCLUSION: Declines in the prevalence of markers of advanced HIV disease at ART initiation probably reflect increasing ART access. However, 12-month LTFU increased during program expansion, and this negated any program improvements in outcomes that might have resulted from earlier ART initiation.
BACKGROUND: During 2004-2009, >12,000 children (<15 years old) initiated antiretroviral therapy (ART) in Mozambique. Nationally representative outcomes and temporal trends in outcomes were investigated. METHODS: Rates of death, loss to follow-up (LTFU) and attrition (death or LTFU) were evaluated in a nationally representative sample of 1054 children, who initiated ART during 2004-2009 at 25 facilities randomly selected using probability-proportional-to-size sampling. RESULTS: At ART initiation during 2004-2009, 50% were male; median age was 3.3 years; median CD4% was 13%; median CD4 count was 375 cells/μL; median weight-for-age Z score was -2.1. During 2004-2009, median time from HIV diagnosis to care initiation declined from 33 to 0 days (P = 0.001); median time from care to ART declined from 93 to 62 days (P = 0.004); the percentage aged <2 at ART initiation increased from 16% to 48% (P = 0.021); the percentage of patients with prior tuberculosis declined from 50% to 10% (P = 0.009); and the percentage with prior lymphocytic interstitial pneumonia declined from 16% to 1% (P < 0.001). Over 2652 person-years of ART, 183 children became LTFU and 26 died. Twelve-month attrition was 11% overall but increased from 3% to 22% during 2004-2009, mainly because of increases in 12-month LTFU (from 3% to 18%). CONCLUSION: Declines in the prevalence of markers of advanced HIV disease at ART initiation probably reflect increasing ART access. However, 12-month LTFU increased during program expansion, and this negated any program improvements in outcomes that might have resulted from earlier ART initiation.
Authors: Taha E Taha; Newton Kumwenda; Amanda Gibbons; Donald Hoover; Valentino Lema; Susan Fiscus; Joshua Mukiibi; George Liomba; Robin Broadhead Journal: AIDS Date: 2002-04-12 Impact factor: 4.177
Authors: Paul Palumbo; Jane C Lindsey; Michael D Hughes; Mark F Cotton; Raziya Bobat; Tammy Meyers; Mutsawashe Bwakura-Dangarembizi; Benjamin H Chi; Philippa Musoke; Portia Kamthunzi; Werner Schimana; Lynette Purdue; Susan H Eshleman; Elaine J Abrams; Linda Millar; Elizabeth Petzold; Lynne M Mofenson; Patrick Jean-Philippe; Avy Violari Journal: N Engl J Med Date: 2010-10-14 Impact factor: 91.245
Authors: Naseem A Ansari; Ally H Kombe; Thomas A Kenyon; Loeto Mazhani; Nancy Binkin; Jordan W Tappero; Tesfaye Gebrekristos; Samabyawo Nyirenda; Sebastian B Lucas Journal: Pediatr Infect Dis J Date: 2003-01 Impact factor: 2.129
Authors: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245
Authors: Franziska Schöni-Affolter; Olivia Keiser; Albert Mwango; Jeffrey Stringer; Bruno Ledergerber; Lloyd Mulenga; Heiner C Bucher; Andrew O Westfall; Alexandra Calmy; Andrew Boulle; Namwinga Chintu; Matthias Egger; Benjamin H Chi Journal: PLoS One Date: 2011-12-19 Impact factor: 3.240
Authors: Richard Makurumidze; Tsitsi Mutasa-Apollo; Tom Decroo; Regis C Choto; Kudakwashe C Takarinda; Janet Dzangare; Lutgarde Lynen; Wim Van Damme; James Hakim; Tapuwa Magure; Owen Mugurungi; Simbarashe Rusakaniko Journal: PLoS One Date: 2020-01-07 Impact factor: 3.240
Authors: Andrew J Prendergast; Alexander J Szubert; Godfrey Pimundu; Chipo Berejena; Pietro Pala; Annie Shonhai; Patricia Hunter; Francesca I F Arrigoni; Victor Musiime; Mutsa Bwakura-Dangarembizi; Philippa Musoke; Hannah Poulsom; Macklyn Kihembo; Paula Munderi; Diana M Gibb; Moira J Spyer; A Sarah Walker; Nigel Klein Journal: AIDS Date: 2021-08-01 Impact factor: 4.177